
Journey Colab: Researching and developing FDA-approved psychedelic therapies for mental health enhancement.
Journey Colab, founded with a mission to revolutionize mental health treatment, focuses on developing FDA-approved psychedelic therapies. The organization aims to harness the promising science behind psychedelics to provide durable remission for individuals suffering from addiction. Their first compound in development is mescaline, and they plan to build a portfolio of plant-identical compounds. Journey Colab integrates psychedelic therapies with psychotherapy and community support to create a comprehensive model of addiction care.
Notable investors back Journey Colab, reflecting confidence in its innovative approach. The organization has made significant strides in real-world research on psychedelic therapeutics, positioning itself as a leader in the emerging field of psychedelic medicine. By pursuing FDA approval and developing effective treatments, Journey Colab aims to make a substantial impact on both individual mental health and broader community well-being.

Woven Science
woven.science

Journey Clinical
journey.clinic

Mindstate Design Labs
mindstate.design

Innerwell
helloinnerwell.com

Maya Health

Lykos Therapeutics
lykospbc.com

Reset Pharmaceuticals

Mindbloom
mindbloom.com

Indigo Lab
labindigo.com

Wonder Sciences
wondersciences.com

Hero Journey Club
herojourney.club

HealingMaps
healingmaps.com

First Person
firstperson.is

Sensorium Therapeutics
sensorium.bio

Hyka
hyka.io
Companies similar to Journey Colab include Woven Science, Journey Clinical, Mindstate Design Labs and Innerwell.
Journey Colab was founded in 2020.
Journey Colab's headquarters is located in San Francisco, CA, US.
Journey Colab's most recent funding round was for $15.7M (USD) in November 2021.
As of Nov 1, 2021, Journey Colab has raised a total of $15.7M (USD).
Journey Colab has 30 employees as of Feb 5, 2024.